首页> 外国专利> DRUG FOR RETINAL DEGENERATIVE DISEASE ASSOCIATED WITH PHOTORECEPTOR DEGENERATION

DRUG FOR RETINAL DEGENERATIVE DISEASE ASSOCIATED WITH PHOTORECEPTOR DEGENERATION

机译:与感光细胞变性相关的视网膜退行性疾病药物

摘要

The present invention addresses the problem of providing a medicine with which it is possible to simply treat and/or prevent retinal degenerative diseases associated with photoreceptor degeneration, including retinitis pigmentosa. The solution is to provide an agent for treating and/or preventing retinal degenerative diseases associated with photoreceptor degeneration, the agent being characterized by containing a compound having a retinoic acid receptor agonistic action (such as tamibarotene, tamibarotene methyl ester, tamibarotene ethyl ester, tazarotene, tazarotenic acid, adapalene, palovalotene, retinol, isotretinoin, alitretinoin, etretinate, acitretin, and bexarotene) or a salt thereof.
机译:本发明解决了提供一种药物的问题,通过该药物可以简单地治疗和/或预防与光感受器变性有关的视网膜变性疾病,包括色素性视网膜炎。该解决方案是提供用于治疗和/或预防与光感受器变性相关的视网膜变性疾病的药物,该药物的特征在于包含具有视黄酸受体激动作用的化合物(例如他米巴罗汀,他米巴罗汀甲酯,他米巴罗汀乙酯,他扎罗汀) ,他扎罗汀酸,阿达帕林,palovalotene,视黄醇,异维A酸,铝维A,维甲酸,阿维A和贝沙罗汀)或其盐。

著录项

  • 公开/公告号WO2019009265A1

    专利类型

  • 公开/公告日2019-01-10

    原文格式PDF

  • 申请/专利权人 DAIICHI SANKYO COMPANY LIMITED;

    申请/专利号WO2018JP25122

  • 发明设计人 TSUJI NAOKI;UENO MASUMI;

    申请日2018-07-03

  • 分类号A61K45;A01K67/027;A61K31/07;A61K31/192;A61K31/203;A61K31/232;A61K31/415;A61K31/4436;A61K31/455;A61K35/545;A61L27/36;A61L27/38;A61P27/02;A61P43;C12N5/073;C12N5/074;C12N15/90;G01N33/15;G01N33/50;

  • 国家 WO

  • 入库时间 2022-08-21 11:57:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号